Posted on 9/22/16
Better Buy: Procter & Gamble vs. Johnson & Johnson
If you're looking for a blue chip stock with a stellar track record of dividend hikes, you're bound to keep bumping into Procter & Gamble (NYSE:PG) . . .
Posted on 9/22/16
McKesson Pharmacy Systems Launches Pharmaserv 7.5
MOON TOWNSHIP, Pa.--(BUSINESS WIRE)--McKesson Pharmacy Systems is pleased to announce the release of Pharmaserv version 7.5 for general availability. The centerpiece of this new release is . . .
Posted on 9/21/16
Admera Health Expands its Next Generations Sequencing Based Pharmacogenomics Test with Update to PGxOne Plus
SOUTH PLAINFIELD, N.J., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Molecular Diagnostics company, Admera Health, (www.admerahealth.com) today announced that its PGxOne™ Plus pharmacogenomics test has been updated . . .
Posted on 9/22/16
Abeona Therapeutics Licenses Next Generation AAV Gene Therapy Vector Platform from The University of North Carolina at Chapel Hill
Abeona Therapeutics Inc., a New York City and Cleveland-based clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, announced the exclusive worldwide license . . .
Posted on 9/21/16
Johnson & Johnson's Smart (Yet Surprising) Acquisition
JOHNSON & JOHNSON'S CEO ALEX GORSKY. IMAGE SOURCE: JOHNSON & JOHNSON.Healthcare conglomerate Johnson & Johnson (NYSE:JNJ), the largest publicly traded healthcare company in the U.S., has . . .
Posted on 9/21/16
Why PTC Therapeutics, Inc. Gave Back As Much As 10% on Tuesday
IMAGE SOURCE: GETTY IMAGES.What happenedShares of PTC Therapeutics (NASDAQ:PTCT), a biopharmaceutical company focused on the development of small-molecule drugs that target post-transcriptional control processes, tumbled as . . .
Posted on 9/20/16
Hepatitis B Foundation Launches Comprehensive New Website to Celebrate 25th Anniversary
National nonprofit’s new website offers improved user experience, simplified navigation as a trusted global authority for information about hepatitis B.The Hepatitis B Foundation is proud to . . .
Posted on 9/20/16
Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016
WARREN, N.J., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the planned transition of Fabian Tenenbaum, current Chief . . .
Posted on 9/20/16
Zynerba Pharmaceuticals Revaluation Imminent
We've seen some decent takeout deals this year in biotech, notably Pfizer's (NYSE:PFE) $14 billion purchase of Medivation at a 180% premium to when takeover talks . . .
Posted on 9/19/16
Hemispherx Biopharma Regains Compliance with NYSE MKT Continued Listing Standards
PHILADELPHIA, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB), announced today that, based on a notice received on September 15, 2016 from the New . . .
Posted on 9/18/16
Roka Bioscience Prices Private Placement of Preferred Stock and Warrants
Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced that it has entered . . .
Posted on 9/16/16
Better Buy: Pfizer Inc. vs. AbbVie Inc.
IMAGE SOURCE: GETTY IMAGES.Big pharma is on a roll.Several of the largest drugmakers' stocks are up by double-digit percentages over the past six months. Count AbbVie . . .
Posted on 9/16/16
5 Reasons Celgene Is a Buy
IMAGE SOURCE: CELGENE While the past few months have been good to Celgene (NASDAQ:CELG) investors, shares are still down about 11% year to date, dramatically underperforming . . .
Posted on 9/16/16
National Business Group on Health Honors Teva Pharmaceuticals with Best Employers for Healthy Lifestyles Award
NORTH WALES, Pa.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. today announced that the National Business Group on Health (NBGH), a non-profit association of 425 large U.S. employers, honored . . .
Posted on 9/14/16
Ferring Pharmaceuticals Recognized as the Nation’s Most Adoption-Friendly Workplace by Dave Thomas Foundation for Adoption
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals was recognized as the most Adoption-Friendly Workplace in the United States by the Dave Thomas Foundation for Adoption, America’s only nonprofit public . . .
Posted on 9/14/16
Why Pfizer's Stock Is a Big Gamble Right Now
IMAGE SOURCE: GETTY IMAGES.Since the failure of Pfizer's (NYSE:PFE) $160 billion megadeal to buy Allergan and move its headquarters, on paper, to lower-tax Ireland, shares of . . .
Posted on 9/21/16
A Video Conversation with Rick Birkmeyer, CEO of CD Diagnostics - Part III
Brought to you by Newmark Grubb Knight Frank
Posted on 9/19/16
A Video Conversation with Rick Birkmeyer, CEO of CD Diagnostics - Part II
Brought to you by Newmark Grubb Knight Frank
Posted on 9/14/16
Zynerba Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer
DEVON, Pa., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid . . .
Posted on 9/15/16
A Video Conversation with Rick Birkmeyer, CEO of CD Diagnostics - Part I
Brought to you by Newmark Grubb Knight Frank
Posted on 9/13/16
Matinas BioPharma Completes Private Placement of $8.0 Million
BEDMINSTER, N.J., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad . . .
Posted on 9/14/16
Reproductive Medicine Associates of New Jersey to Offer Free Physicians' Webinar Series on Infertility
Five-Part Series to Feature Q&A and cover topics such as IUI, IVF, Egg Freezing, AMH Screening, LGBT Family Building, Fertility Financials, and morePhysicians from Reproductive Medicine Associates . . .
Posted on 9/12/16
2 Companies Johnson & Johnson Should Consider Buying
JOHNSON & JOHNSON'S STRAIGHT-SHOOTING CEO, ALEX GORSKY. IMAGE SOURCE: JOHNSON & JOHNSON.Healthcare conglomerate Johnson & Johnson (NYSE:JNJ) is a staple holding for quite a few long-term . . .
Posted on 9/12/16
3 All-or-Nothing Biotechs I'm Watching Like a Hawk
IMAGE SOURCE: GETTY IMAGES.Every small-cap biotech stock whose future depends on the success of a single compound will eventually face a binary event. Whether that event . . .
Posted on 9/12/16
3 Stocks to Avoid in the Biotechnology Sector
IMAGE SOURCE: GETTY IMAGES.Perhaps more than any other industry, biotechnology start-ups face long, treacherous paths to profitability, and a majority never make it. If you think . . .
Philadelphia
